Tirzepatide 50mg

Tirzepatide 50 mg Injection is an advanced formulation designed to achieve exceptional outcomes in Type 2 Diabetes Mellitus and obesity management. BLUEPILL EXPRESS, a leading merchant exporter, offers this product with manufacturing facilities in India and China depending on the client’s requirement. The dual GIP and GLP-1 receptor agonist mechanism delivers powerful glucose control and significant body weight reduction. The formulation ensures improved insulin sensitivity, appetite regulation, and metabolic balance.
Mechanism of Action: Tirzepatide acts on two key receptors, GIP and GLP-1, to enhance insulin secretion, suppress glucagon levels, delay gastric emptying, and promote satiety. This dual mechanism improves blood glucose regulation and supports healthy weight loss.
Therapeutic Indications: Type 2 Diabetes Mellitus management in adults not adequately controlled with diet, exercise, or oral antidiabetic drugs. Long-term weight management for obese or overweight adults. Reduction of cardiovascular and metabolic risks associated with diabetes.
Dosage and Administration: Administered once weekly by subcutaneous injection in the abdomen, thigh, or upper arm. Initial dose 2.5 mg weekly, titrated gradually to 50 mg under medical supervision. Dosing should be consistent each week.
Pharmacological Classification: Therapeutic Category – Antidiabetic/Anti-obesity Agent; Drug Class – Dual GIP & GLP-1 Receptor Agonist; ATC Code – A10BJ06.
Benefits: Superior glucose control and weight reduction efficacy. Once-weekly dosing enhances compliance. Reduction of HbA1c and body weight simultaneously. Helps improve lipid profile and cardiovascular parameters. Manufactured under WHO-GMP and ISO-certified standards in India and China. Ideal for bulk export, third-party manufacturing, and private labeling.
Precautions and Warnings: Not recommended for Type 1 Diabetes or diabetic ketoacidosis. Contraindicated in patients with medullary thyroid carcinoma or MEN2. Use cautiously in patients with pancreatitis or renal impairment. Common side effects include nausea, vomiting, and reduced appetite. Not recommended for pregnant or lactating women.
Storage and Handling: Store between 2°C to 8°C. Do not freeze. Protect from direct sunlight and maintain cold chain during shipment.
Manufacturing and Quality Assurance: BLUEPILL EXPRESS ensures manufacturing in WHO-GMP and ISO-certified plants in India and China. Every batch is tested for potency, purity, and sterility. Manufacturing follows IP/BP/USP pharmacopoeial standards and strict GMP compliance.
Export and Documentation Support: BLUEPILL EXPRESS provides COA, COO, Stability Report, MSDS, and Batch Manufacturing Record. Complete regulatory and export documentation support available for global clients.
Why Choose BLUEPILL EXPRESS: BLUEPILL EXPRESS is a trusted global merchant exporter offering flexible sourcing from India and China. The company guarantees international-quality standards, cold-chain integrity, and export compliance. Services include private labeling, customized packaging, and regulatory dossier support.
Clinical Efficacy: Clinical studies demonstrate significant HbA1c reduction and up to 22% body weight loss at higher doses like Tirzepatide 50 mg. Proven benefits for long-term glycemic stability and cardiovascular health.
Global Distribution: BLUEPILL EXPRESS exports Tirzepatide 50 mg Injection globally, including to Asia, Africa, Europe, and Latin America. Available for hospitals, tenders, and private-label contracts.
Conclusion: Tirzepatide 50 mg Injection represents the next-generation incretin therapy offering unmatched results in Type 2 Diabetes and obesity management. With manufacturing capabilities in India and China, BLUEPILL EXPRESS ensures quality, affordability, and global supply reliability as a leading merchant exporter of advanced diabetic therapies.